Association between Immune Recovery Uveitis and a Diverse Intraocular Cytomegalovirus-Specific Cytotoxic T Cell Response

Journal of Infectious Diseases, Sep 2002

Cytomegalovirus (CMV) causes serious infection in individuals with deficient T cell immunity. In acquired immunodeficiency syndrome, the retina is a major site of progressive infection, despite the availability of therapy that targets CMV. The administration of highly active antiretroviral therapy to suppress human immunodeficiency virus frequently results in resolution of CMV retinitis, but this may be complicated by ocular inflammation termed “immune recovery uveitis” (IRU). To provide insight into the pathogenesis of IRU, the phenotype and specificity of intraocular T cells in a single patient were analyzed. The T cell infiltrate consisted of a diverse population of CD8+ CMV-specific T cells, but only a minority of these T cells recognized the CMV phosphoprotein 65 and immediate early protein 1, which have been considered major targets of the host response. These results imply that reconstitution of CMV-specific T cells plays a role in IRU and suggest that the specificity of T cells engaged in the control of CMV at local sites of reactivation may be broad

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://jid.oxfordjournals.org/content/186/5/701.full.pdf

Association between Immune Recovery Uveitis and a Diverse Intraocular Cytomegalovirus-Specific Cytotoxic T Cell Response

Association between Immune Recovery Uveitis and a Diverse Intraocular Cytomegalovirus-Specific Cytotoxic T Cell Response Helen P. Mutimer 1 2 Yoshiki Akatsuka 1 2 3 Thomas Manley 1 2 Elaine L. Chuang 1 Michael Boeckh 0 1 2 Robert Harrington 0 1 Thomas Jones 1 4 Stanley R. Riddell 0 1 2 0 Medicine, University of Washington , Seattle 1 Received 26 December 2001; revised 18 April 2002; electronically published 5 August 2002. Informed consent was obtained from patients, and the human experimen- tation guidelines of the US Department of Health and Human Services were followed in conducting this research. Financial support: National Institutes of Health (CA-18029 and AI-41754 to S.R.R.) 2 Program in Immunology, Fred Hutchinson Cancer Research Center, and Departments of 3 Present affiliation: Division of Immunology, Aichi Cancer Center , Nagoya , Japan. inson Cancer Research Ctr. , 1100 Fairview Ave. N, Seattle, WA 98109 (sriddell @fhcrc.org) 4 Wyeth Ayerst , Pearl River , New York Cytomegalovirus (CMV) causes serious infection in individuals with deficient T cell immunity. In acquired immunodeficiency syndrome, the retina is a major site of progressive infection, despite the availability of therapy that targets CMV. The administration of highly active antiretroviral therapy to suppress human immunodeficiency virus frequently results in resolution of CMV retinitis, but this may be complicated by ocular inflammation termed “immune recovery uveitis” (IRU). To provide insight into the pathogenesis of IRU, the phenotype and specificity of intraocular T cells in a single patient were analyzed. The T cell infiltrate consisted of a diverse population of CD8+ CMV-specific T cells, but only a minority of these T cells recognized the CMV phosphoprotein 65 and immediate early protein 1, which have been considered major targets of the host response. These results imply that reconstitution of CMV-specific T cells plays a role in IRU and suggest that the specificity of T cells engaged in the control of CMV at local sites of reactivation may be broad. - T cells are crucial for preventing cytomegalovirus (CMV) disease. Before highly active antiretroviral therapy (HAART) became available, individuals with T cell depletion due to human immunodeficiency virus (HIV) commonly developed CMV infection [1]. In such patients, retinitis is the most frequent complication, resulting in vision loss due to cytopathic infection of retinal cells and macular edema. The availability of HAART has reduced the incidence of CMV retinitis, and it has been possible to discontinue anti-CMV drugs in most patients with retinitis who experience an increase in CD4 T cells [2]. A new syndrome, termed “immune recovery uveitis” (IRU), which is characterized by ocular inflammation and decreased vision without active CMV replication, is observed in HIVpositive individuals who recover from CMV retinitis [3]. The pathogenesis of IRU is unknown, but the association with improvement in T cell numbers suggests that infiltration of T cells Methods Study participant. Vitreous humor was obtained from an HIVpositive patient with IRU. This individual developed CMV retinitis in 1996 while receiving lamivudine and stavudine for HIV infection and ganciclovir for CMV enteritis. When CMV retinitis developed, the patient’s CD4 T cell count was 20 cells/mm3, and the HIV load was 73,000 copies/mL. Cidofovir was administered intravenously, and CMV retinitis became inactive. Indinavir was added to lamivudine and stavudine in October 1996. In March 1998, the patient’s plasma HIV load was undetectable, and the CD4 T cell count increased to 140 cells/mm3. In March 1999, the patient’s CD4 T cell count increased to 370 cells/mm3, but inflammation developed in the left eye, and visual acuity declined. Pars plana vitrectomy was performed to improve vision, and vitreous humor and blood samples were obtained for analysis. Cell lines and viruses. Fibroblasts and Epstein-Barr virus– transformed B lymphoblastoid cell lines (LCLs) were generated and propagated as described elsewhere [4]. CMV AD169 was obtained from the American Tissue Culture Collection, and supernatant virus was produced by passage in fibroblasts [4]. The mutant CMV strain RV798, which was constructed with a deletion of the unique short (US) region, was propagated similarly [5]. Vaccinia recombinant viruses encoding the immediate early protein 1 (Vac/ IE-1), pp65 (Vac/pp65), and gB (Vac/gB) were provided by William Britt (University of Alabama, Birmingham). T cell clones. Cells were pelleted from the vitreous humor and resuspended in RPMI 1640 medium containing 10% human serum, 50 U/mL interleukin-2, and 30 ng/mL anti-CD3 monoclonal antibody (MAb). Cells were plated at 0.5 cells/well with 7.5 104 gamma-irradiated peripheral blood mononuclear cells (PBMC) and 1 104 gamma-irradiated LCLs as feeder cells. T cells in wells in which growth was evident after 14 days were expanded by restimulation with anti-CD3. CD8 T cell cl (...truncated)


This is a preview of a remote PDF: https://jid.oxfordjournals.org/content/186/5/701.full.pdf

Helen P. Mutimer, Yoshiki Akatsuka, Thomas Manley, Elaine L. Chuang, Michael Boeckh, Robert Harrington, Thomas Jones, Stanley R. Riddell. Association between Immune Recovery Uveitis and a Diverse Intraocular Cytomegalovirus-Specific Cytotoxic T Cell Response, Journal of Infectious Diseases, 2002, pp. 701-705, 186/5, DOI: 10.1086/342044